The $35 billion race to cure a liver disease that affects 30 million Americans

In the U.S., 30 million people are suffering from a form of fatty liver disease that progresses into a form of liver cirrhosis that eventually leads to death, unless a patient can receive a liver transplant. Yet there is no screening for it and no FDA-approved treatment available. Now drug companies are spending billions to help find a cure.